Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: A retrospective review of 216 patients

Bone Marrow Transplantation

Volumn 32, Issue 8, 2003, Pages 809-813

  Choi, S J ^a   Lee, K H ^a   Lee, J H ^a,a   Kim, S ^a   Seol, M ^a   Lee, Y S ^a   Kim, W K ^a   Park, C J ^b   Chi, H S ^b   Lee, J S ^a  

^a Asan Medical Center   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Allogeneic hematopoietic cell transplantation; Engraftment syndrome; Graft venous host disease; Peri engraftment clinical abnormality

Indexed keywords

ACICLOVIR; AMIKACIN; AMPHOTERICIN B; BUSULFAN; CEFTAZIDIME; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; PIPERACILLIN; THYMOCYTE ANTIBODY; VANCOMYCIN;

ACUTE GRAFT REJECTION; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; APLASTIC ANEMIA; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DONOR; FEBRILE NEUTROPENIA; FEMALE; FEVER; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY FAILURE; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; NEPHROTOXICITY; NEWBORN; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; RETROSPECTIVE STUDY; REVIEW; STATISTICAL SIGNIFICANCE; VEIN OCCLUSION; WEIGHT GAIN;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CAPILLARY PERMEABILITY; FEMALE; FEVER; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; KIDNEY FAILURE; LIVER DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TRANSPLANTATION, HOMOLOGOUS; WEIGHT GAIN;

EID: 11144354975     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704224     Document Type: Review

References (11)

1. Lee CK, Gingrich RD, Hohl RJ, Ajram KA. Engraftment syndrome in autologous bone marrow and peripheral stem cell transplantation. Bone Marrow Transplant 1995; 16: 175-182.
2. Ravoet C, Feremans W, Husson B et al. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation. Bone Marrow Transplant 1996; 18: 943-947.
3. Spitzer TR. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 2001; 27: 893-898.
4. Cahill RA, Spitzer TR, Mazumder A et al. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996; 18: 177-184.
5. Nurnberger W, Willers R, Burdach S, Gobel U. Risk factors for capillary leakage syndrome after bone marrow transplantation. Ann Hematol 1997; 74: 221 224.
6. Colby C, McAfee S, Sackstein R et al. Engraftment syndrome following non-myeloablative conditioning therapy and HLA-matched bone marrow transplantation for hematologic malignancy. Blood 2000; 96: 520a [abstract].
7. Lee KH, Lee JH et al. Non-myeloablative conditioning regimen of fludarabine, busulfan, anti-thymocyte globulin, and methylprednisolone for allogeneic peripheral blood hematopoietic cell transplantation. Haematologica 2001; 86: 999-1001.
8. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1996; 15: 825-828.
9. Sullivan KM. Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986; 4: 42-93.
10. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients. Ann Intern Med 1993; 118: 255-267.
11. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989; 320: 365-376.